{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:33:04Z","timestamp":1707525184219},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,12]]},"DOI":"10.7759\/cureus.43372","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T14:05:21Z","timestamp":1691849121000},"source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Catheter Ablation in Left Ventricular Ejection Fraction, Stroke, Quality of Life, All-Cause Mortality, Sinus Rhythm Maintenance, and Hospitalization Rates as Compared to Medical Therapy"],"prefix":"10.7759","author":[{"given":"Mrinal J P","family":"Oble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsun Nahar","family":"Sonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherie","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srushti R","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneeque","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Dheeraj","family":"Gutlapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marya","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihan","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Atrial fibrillation","author":"Michaud GF","year":"2018","unstructured":"Michaud GF, Stevenson WG. Atrial fibrillation . Harrison's Principles of Internal Medicine. Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (ed): McGraw Hill, 2018. 20:"},{"key":"ref2","article-title":"Heart failure","author":"Kasper","year":"2017","unstructured":"Kasper, Fauci AS, Hauser SL, et al.. Heart failure. Harrison's Manual of Medicine. McGraw Hill Inc, 2017."},{"key":"ref3","unstructured":"Cardiac ablation. (2022). Accessed. February 22, 2022: https:\/\/www.mayoclinic.org\/tests-procedures\/cardiac-ablation\/about\/pac-20384993."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association","volume":"139","author":"Benjamin EJ","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al.. Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation. 2019, 139:e56-e528. 10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. About multiple cause of death, 1999-2019. CDC WONDER online database website. Atlanta, GA. Centers for Disease Control and Prevention. (2019). Accessed: February 1, 2021: https:\/\/wonder.cdc.gov\/wonder\/help\/mcd.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193996","article-title":"Leading causes of cardiovascular hospitalization in 8.45 million US veterans","volume":"13","author":"Krishnamurthi N","year":"2018","unstructured":"Krishnamurthi N, Francis J, Fihn SD, Meyer CS, Whooley MA. Leading causes of cardiovascular hospitalization in 8.45 million US veterans. PLoS One. 2018, 13:e0193996. 10.1371\/journal.pone.0193996","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140047","article-title":"Atrial fibrillation: mechanisms, therapeutics, and future directions","volume":"5","author":"Pellman J","year":"2015","unstructured":"Pellman J, Sheikh F. Atrial fibrillation: mechanisms, therapeutics, and future directions. Compr Physiol. 2015, 5:649-65. 10.1002\/cphy.c140047","journal-title":"Compr Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5772\/2490","article-title":"Pulmonary venous flow pattern and atrial fibrillation: fact and controversy","author":"Maruyama T","year":"2012","unstructured":"Maruyama T, Kokawa Y, Nakamura H, Fukata M, Yasuda S, Odashiro K, Akashi K. Pulmonary venous flow pattern and atrial fibrillation: fact and controversy . Echocardiography. Bajraktari G (ed): Intech open, 2012. 77-92. 10.5772\/2490"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2231-0770.173580","article-title":"The current approach of atrial fibrillation management","volume":"6","author":"Amin A","year":"2016","unstructured":"Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna J Med. 2016, 6:8-16. 10.4103\/2231-0770.173580","journal-title":"Avicenna J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195530","article-title":"Catheter ablation versus medical therapy of atrial fibrillation in patients with heart failure: An updated systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Magnocavallo M","year":"2022","unstructured":"Magnocavallo M, Parlavecchio A, Vetta G, et al.. Catheter ablation versus medical therapy of atrial fibrillation in patients with heart failure: An updated systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2022, 11:5530. 10.3390\/jcm11195530","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310391","article-title":"Pathophysiology, diagnosis and treatment of tachycardiomyopathy","volume":"103","author":"Martin CA","year":"2017","unstructured":"Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart. 2017, 103:1543-52. 10.1136\/heartjnl-2016-310391","journal-title":"Heart"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000040","article-title":"Novel perspectives on arrhythmia-induced cardiomyopathy: pathophysiology, clinical manifestations and an update on invasive management strategies","volume":"23","author":"Della Rocca DG","year":"2015","unstructured":"Della Rocca DG, Santini L, Forleo GB, et al.. Novel perspectives on arrhythmia-induced cardiomyopathy: pathophysiology, clinical manifestations and an update on invasive management strategies. Cardiol Rev. 2015, 23:135-41. 10.1097\/CRD.0000000000000040","journal-title":"Cardiol Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jce.14638","article-title":"Non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: implications of pathophysiology for catheter ablation","volume":"31","author":"Della Rocca DG","year":"2020","unstructured":"Della Rocca DG, Tarantino N, Trivedi C, et al.. Non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: implications of pathophysiology for catheter ablation. J Cardiovasc Electrophysiol. 2020, 31:2154-67. 10.1111\/jce.14638","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan R","year":"2016","unstructured":"Santhanakrishnan R, Wang N, Larson MG, et al.. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016, 133:484-92. 10.1161\/CIRCULATIONAHA.115.018614","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz443","article-title":"Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data","volume":"41","author":"Chen S","year":"2020","unstructured":"Chen S, P\u00fcrerfellner H, Meyer C, et al.. Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data. Eur Heart J. 2020, 41:2863-73. 10.1093\/eurheartj\/ehz443","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-1423","article-title":"Treatment strategies for atrial fibrillation with left ventricular systolic dysfunction \u2015 meta-analysis","volume":"82","author":"Ahn J","year":"2018","unstructured":"Ahn J, Kim HJ, Choe JC, et al.. Treatment strategies for atrial fibrillation with left ventricular systolic dysfunction \u2015 meta-analysis. Circ J. 2018, 82:1770-7. 10.1253\/circj.CJ-17-1423","journal-title":"Circ J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2012.03513.x","article-title":"Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis","volume":"36","author":"Chatterjee S","year":"2013","unstructured":"Chatterjee S, Sardar P, Lichstein E, Mukherjee D, Aikat S. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol. 2013, 36:122-33. 10.1111\/j.1540-8159.2012.03513.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2020.11.021","article-title":"Atrial fibrillation burden and clinical outcomes in heart failure: The CASTLE-AF trial","volume":"7","author":"Brachmann J","year":"2021","unstructured":"Brachmann J, Sohns C, Andresen D, et al.. Atrial fibrillation burden and clinical outcomes in heart failure: The CASTLE-AF trial\r\n. JACC Clin Electrophysiol. 2021, 7:594-603. 10.1016\/j.jacep.2020.11.021","journal-title":"JACC Clin Electrophysiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study","volume":"70","author":"Prabhu S","year":"2017","unstructured":"Prabhu S, Taylor AJ, Costello BT, et al.. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study. J Am Coll Cardiol. 2017, 70:1949-61. 10.1016\/j.jacc.2017.08.041","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.05.011","article-title":"2016 ACC\/AHA\/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: an update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines and the Heart Failure Society of America","volume":"68","author":"Yancy CW","year":"2016","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2016 ACC\/AHA\/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: an update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016, 68:1476-88. 10.1016\/j.jacc.2016.05.011","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al.. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014, 130:2071-104. 10.1161\/CIR.0000000000000040","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14178","article-title":"Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid-range ejection fraction","volume":"10","author":"Lee DY","year":"2023","unstructured":"Lee DY, Chang TY, Chang SL, et al.. Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid-range ejection fraction. ESC Heart Fail. 2023, 10:177-88. 10.1002\/ehf2.14178","journal-title":"ESC Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026054","article-title":"Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction","volume":"135","author":"Verma A","year":"2017","unstructured":"Verma A, Kalman JM, Callans DJ. Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction. Circulation. 2017, 135:1547-63. 10.1161\/CIRCULATIONAHA.116.026054","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12602","article-title":"Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction","volume":"26","author":"Bunch TJ","year":"2015","unstructured":"Bunch TJ, May HT, Bair TL, et al.. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2015, 26:363-70. 10.1111\/jce.12602","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-020-00727-9","article-title":"Catheter ablation of atrial fibrillation in heart failure: clinical, prognostic, and echocardiographic outcome","volume":"60","author":"Cirasa A","year":"2021","unstructured":"Cirasa A, La Greca C, Pecora D, Sorgato A, Simoncelli U, Campana M, Cuccia C. Catheter ablation of atrial fibrillation in heart failure: clinical, prognostic, and echocardiographic outcome. J Interv Card Electrophysiol. 2021, 60:221-9. 10.1007\/s10840-020-00727-9","journal-title":"J Interv Card Electrophysiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-017-9657-9","article-title":"Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure","volume":"23","author":"Hohendanner F","year":"2018","unstructured":"Hohendanner F, Heinzel FR, Blaschke F, Pieske BM, Haverkamp W, Boldt HL, Parwani AS. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Fail Rev. 2018, 23:27-36. 10.1007\/s10741-017-9657-9","journal-title":"Heart Fail Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-018-0349-8","article-title":"Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials","volume":"52","author":"Chen C","year":"2018","unstructured":"Chen C, Zhou X, Zhu M, et al.. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials. J Interv Card Electrophysiol. 2018, 52:9-18. 10.1007\/s10840-018-0349-8","journal-title":"J Interv Card Electrophysiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche NF","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, et al.. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018, 378:417-27. 10.1056\/NEJMoa1707855","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont L","year":"2014","unstructured":"Mont L, Bisbal F, Hern\u00e1ndez-Madrid A, et al.. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014, 35:501-7. 10.1093\/eurheartj\/eht457","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-018-0425-0","article-title":"Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials","volume":"53","author":"Brice\u00f1o DF","year":"2018","unstructured":"Brice\u00f1o DF, Markman TM, Lupercio F, et al.. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2018, 53:19-29. 10.1007\/s10840-018-0425-0","journal-title":"J Interv Card Electrophysiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7326\/ACPJC-2018-168-10-055","article-title":"In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF","volume":"168","author":"Greet B","year":"2018","unstructured":"Greet B, Schurmann P, Deswal A. In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF. Ann Intern Med. 2018, 168:JC55. 10.7326\/ACPJC-2018-168-10-055","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones DG","year":"2013","unstructured":"Jones DG, Haldar SK, Hussain W, et al.. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013, 61:1894-903. 10.1016\/j.jacc.2013.01.069","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":": Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase L","year":"2016","unstructured":"Di Biase L, Mohanty P, Mohanty S, et al.. : Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016, 133:1637-44. 10.1161\/CIRCULATIONAHA.115.019406","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.191","article-title":"Comorbidity of atrial fibrillation and heart failure","volume":"13","author":"Ling LH","year":"2016","unstructured":"Ling LH, Kistler PM, Kalman JM, Schilling RJ, Hunter RJ. Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol. 2016, 13:131-47. 10.1038\/nrcardio.2015.191","journal-title":"Nat Rev Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0946-6","article-title":"Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment","volume":"18","author":"Jarman JW","year":"2018","unstructured":"Jarman JW, Hussain W, Wong T, et al.. Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment. BMC Cardiovasc Disord. 2018, 18:211. 10.1186\/s12872-018-0946-6","journal-title":"BMC Cardiovasc Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jce.15317","article-title":"Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom","volume":"33","author":"Leung LW","year":"2022","unstructured":"Leung LW, Imhoff RJ, Marshall HJ, et al.. Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom. J Cardiovasc Electrophysiol. 2022, 33:164-75. 10.1111\/jce.15317","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.01.043","article-title":"Stroke and cardiovascular events after ablation or antiarrhythmic drugs for treatment of patients with atrial fibrillation","volume":"121","author":"Mansour M","year":"2018","unstructured":"Mansour M, Heist EK, Agarwal R, Bunch TJ, Karst E, Ruskin JN, Mahapatra S. Stroke and cardiovascular events after ablation or antiarrhythmic drugs for treatment of patients with atrial fibrillation. Am J Cardiol. 2018, 121:1192-9. 10.1016\/j.amjcard.2018.01.043","journal-title":"Am J Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/pace.14013","article-title":"Thirty-day readmissions after atrial fibrillation catheter ablation in patients with heart failure","volume":"43","author":"Lima FV","year":"2020","unstructured":"Lima FV, Kennedy KF, Sheikh W, et al.. Thirty-day readmissions after atrial fibrillation catheter ablation in patients with heart failure. Pacing Clin Electrophysiol. 2020, 43:930-40. 10.1111\/pace.14013","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23314","article-title":"Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction","volume":"43","author":"Long S","year":"2020","unstructured":"Long S, Xi Y, Gao L, et al.. Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction. Clin Cardiol. 2020, 43:305-14. 10.1002\/clc.23314","journal-title":"Clin Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321196","article-title":"Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank","volume":"108","author":"Kany S","year":"2022","unstructured":"Kany S, Cardoso VR, Bravo L, et al.. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank. Heart. 2022, 108:1873-80. 10.1136\/heartjnl-2022-321196","journal-title":"Heart"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/jce.14429","article-title":"Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: a meta-analysis","volume":"31","author":"Saglietto A","year":"2020","unstructured":"Saglietto A, De Ponti R, Di Biase L, et al.. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: a meta-analysis. J Cardiovasc Electrophysiol. 2020, 31:1040-7. 10.1111\/jce.14429","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.03.068","article-title":"Association of catheter ablation for atrial fibrillation with mortality and stroke: a systematic review and meta-analysis","volume":"266","author":"Barra S","year":"2018","unstructured":"Barra S, Baran J, Narayanan K, et al.. Association of catheter ablation for atrial fibrillation with mortality and stroke: a systematic review and meta-analysis. Int J Cardiol. 2018, 266:136-42. 10.1016\/j.ijcard.2018.03.068","journal-title":"Int J Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84256-z","article-title":"Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure","volume":"11","author":"Yang PS","year":"2021","unstructured":"Yang PS, Kim D, Sung JH, et al.. Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure. Sci Rep. 2021, 11:4694. 10.1038\/s41598-021-84256-z","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-020-00435-9","article-title":"Long-term outcomes and improvements in quality of life in patients with atrial fibrillation treated with catheter ablation vs. antiarrhythmic drugs","volume":"21","author":"Zheng ZH","year":"2021","unstructured":"Zheng ZH, Fan J, Ji CC, Cheng YJ, Chen XM, Jiang JZ, Wu SH.  Long-term outcomes and improvements in quality of life in patients with atrial fibrillation treated with catheter ablation vs. antiarrhythmic drugs. Am J Cardiovasc Drugs. 2021, 21:299-320. 10.1007\/s40256-020-00435-9","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2012.02419.x","article-title":"Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function","volume":"24","author":"Anselmino M","year":"2013","unstructured":"Anselmino M, Grossi S, Scaglione M, et al.. Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function. J Cardiovasc Electrophysiol. 2013, 24:24-32. 10.1111\/j.1540-8167.2012.02419.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa356","article-title":"Long-term observation of catheter ablation vs. pharmacotherapy in the management of persistent and long-standing persistent atrial fibrillation (CAPA study)","volume":"23","author":"Wu G","year":"2021","unstructured":"Wu G, Huang H, Cai L, et al.. Long-term observation of catheter ablation vs. pharmacotherapy in the management of persistent and long-standing persistent atrial fibrillation (CAPA study). Europace. 2021, 23:731-9. 10.1093\/europace\/euaa356","journal-title":"Europace"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-018-1194-5","article-title":"Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry","volume":"33","author":"An Y","year":"2018","unstructured":"An Y, Esato M, Ishii M, et al.. Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry. Heart Vessels. 2018, 33:1534-46. 10.1007\/s00380-018-1194-5","journal-title":"Heart Vessels"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade JG","year":"2021","unstructured":"Andrade JG, Wells GA, Deyell MW, et al.. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021, 384:305-15. 10.1056\/NEJMoa2029980","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer DL","year":"2021","unstructured":"Packer DL, Piccini JP, Monahan KH, et al.. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021, 143:1377-90. 10.1161\/CIRCULATIONAHA.120.050991","journal-title":"Circulation"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha D","year":"2014","unstructured":"Kotecha D, Holmes J, Krum H, et al.. Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.  Lancet. 2014, 384:2235-43. 10.1016\/S0140-6736(14)61373-8","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2019.02.014","article-title":"Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"74","author":"Machino-Ohtsuka T","year":"2019","unstructured":"Machino-Ohtsuka T, Seo Y, Ishizu T, et al.. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation. J Cardiol. 2019, 74:235-44. 10.1016\/j.jjcc.2019.02.014","journal-title":"J Cardiol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter RJ","year":"2014","unstructured":"Hunter RJ, Berriman TJ, Diab I, et al.. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014, 7:31-8. 10.1161\/CIRCEP.113.000806","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.114.001938","article-title":"Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"7","author":"Anselmino M","year":"2014","unstructured":"Anselmino M, Matta M, D'Ascenzo F, et al.. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014, 7:1011-8. 10.1161\/CIRCEP.114.001938","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab201","article-title":"Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction","volume":"24","author":"Fujimoto H","year":"2022","unstructured":"Fujimoto H, Doi N, Okayama S. Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction. Europace. 2022, 24:576-86. 10.1093\/europace\/euab201","journal-title":"Europace"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.04.092","article-title":"Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities","volume":"78","author":"Thomas KL","year":"2021","unstructured":"Thomas KL, Al-Khalidi HR, Silverstein AP, et al.. Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities. J Am Coll Cardiol. 2021, 78:126-38. 10.1016\/j.jacc.2021.04.092","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159975-effectiveness-of-catheter-ablation-in-left-ventricular-ejection-fraction-stroke-quality-of-life-all-cause-mortality-sinus-rhythm-maintenance-and-hospitalization-rates-as-compared-to-medical-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:25Z","timestamp":1707509065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159975-effectiveness-of-catheter-ablation-in-left-ventricular-ejection-fraction-stroke-quality-of-life-all-cause-mortality-sinus-rhythm-maintenance-and-hospitalization-rates-as-compared-to-medical-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.43372","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,12]]}}}